Stocks to buy

Some financial traders might be tempted to jump into the trade with Meta Materials (NASDAQ:MMAT) stock because it’s cheap now. Yet, the shares could get cheaper, so be patient. There are news items that could distract some investors, plus economic conditions are challenging as we head into 2023. So, establish a buy price and stick
0 Comments
Despite the frenzy over meme stocks dying down a while ago, plenty of undervalued Reddit stocks are available for investors to pick up. Reddit’s social media platform hosts one of the largest communities of traders. Its r/wallstreetbets community has over 13.3 million members and was responsible for coordinating a short squeeze against GameStop and others.
0 Comments
While most investors should probably steer clear of day trading as the activity could lead to certain legal ramifications, some folks may need to seek short-term stocks for quick gains. In that case, market participants should focus on names that stand poised for big moves. One of the best early warning indicators for the underlying
0 Comments
The U.S. stock market has been spooked by actions of the Federal Reserve. However, as Barron’s pointed out, “Despite the most rapid tightening of financial conditions in a generation, and the turmoil in financial markets, the U.S. economy is entering 2023 in decent shape.” With the labor market and America’s dominant services sector still both strong,
0 Comments
Artificial intelligence has become a powerful driver of innovation in the tech sector in recent years, paving the way for autonomous driving, cybersecurity advancements, and more. But a new advancement by OpenAI – ChatGPT – is changing the landscape again. With its natural language processing capabilities and conversational AI technology, this chatbot can revolutionize how
0 Comments
In 2023, stock market uncertainties will worsen, rewarding investors who seek cheap dividend stocks. The bigger their discount to their fair value, the more margin of safety the company offers. Companies that pay dividends prioritize cash flow first. Management will allocate cash flow to shareholders, rewarding them with a high dividend yield. Finding cheap dividend
0 Comments
With a good deal of pent-up travel demand, keep an eye on experience stocks. For one, according to SWNSDigital.com, 80% of Americans say they need a vacation in 2023 “more than ever before.” Two, according to Hospitalitynet.org, “The most recent American Travel Sentiment Study indicates that 92% of Americans have travel plans in the next six
0 Comments
[embedded content] So, if we’re shorting Tesla (TSLA), should we be buying Rivian (RIVN) and Lucid (LCID) right now? Well, if you’ve been with us for a while, you know our answer is yes. We’re confident that these two companies will win significant market share as their production ramps and that the EV stocks will
0 Comments
Is it a good time to make a small investment in China-based electric vehicle (EV) manufacturer Nio (NYSE:NIO)? Skepticism abounds, but at least one expert on Wall Street has a positive outlook. Listen to what he has to say — and check out Nio’s revamped version of its popular SUV model — and you just might
0 Comments
As technological innovation continues to integrate into everyday functionalities, investors ought to consider the hottest augmented reality stocks to own for 2023 and beyond. To get everyone on the same page, AR refers to platforms that overlay “visual, auditory, or other sensory information onto the real world to enhance one’s experience,” per Investopedia. It’s another
0 Comments
Amid the latest groundbreaking news in the broader energy space, investors may want to target certain long-term stocks to buy on the nuclear fusion announcement. According to The New York Times, scientists at the Lawrence Livermore National Laboratory in California announced a major milestone: they laid the groundwork in reproducing the power of the sun
0 Comments
Some of the hottest biotech stocks are safe and recession-proof. After all, we can’t stop people from aging – at least, not yet. We can’t stop people from seeking treatments for a myriad of issues. Plus, there’s growing demand for innovation in gene therapies, immune-oncology, precision medicine, machine-learning drug discovery, and treatments for unmet medical
0 Comments